Neuromuscular electrical stimulators (NMES) to hit the market
Release time:
2022-03-17
Source:
Warmly celebrate the blockbuster new product independently developed by our company-neuromuscular electrostimulator (NMES) was officially approved for listing on March 15, 2022 (Zhejiang machinery injection quasi -20222090118).
A new era of DVT prevention
Warmly celebrate the blockbuster new product independently developed by our company-neuromuscular electrostimulator (NMES) was officially approved for listing on March 15, 2022 (Zhejiang machinery injection quasi -20222090118).
The product is through the neuromuscular electrical stimulation technology (NMES) to stimulate the peroneal nerve, stimulate the nerve muscle continuous rhythmic contraction, promote ankle flexion, make the muscle active pumping blood to improve the lower limb vein, artery and microcirculation blood. At the same time, NMES has a fibrinolytic effect, can produce a synergistic effect with heparin, and does not affect the user's blood pressure and heart rate.
Product indications
Product advantages
The blockbuster launch of neuromuscular electrostimulator products marks the opening up of a new medical sector for Haichuang Medical, providing a richer selection of products for clinical use in the DVT field. At the same time, it has also taken a solid step for the diversified development of enterprises, and also marks that our R & D technology capability has reached a new level.
Related News
A technology-based enterprise focusing on R&D and production of innovative medical consumable products
MessageAddress:
F1, Building 3, No. 509, Hongfeng Road, Linping, Yuhang Economic Development, Hangzhou, Zhejiang
TEL:
E-mail:
Copyright©2020 Zhejiang Haichuang Medical Equipment Co., Ltd. Powered by www.300.cn